Skip to main content

FDA recall, , Moderate risk

Mellish Island Super Skin Dietary Supplement

Firm's finished product label does not declare the source of marine collagen which was determined to be fish.

What happened

Mellish Island Corp of San Dimas, California, recalled its Mellish Island Super Skin dietary supplement, sold in 60-capsule bottles, 2 per day, because the finished product label does not declare the source of marine collagen, which was determined to be fish. The company began the recall on July 1, 2026, and the FDA added it to its Enforcement Report on July 28, 2026. The product was distributed through TikTok exclusively, presumably nationwide, and the recall involved 1,600 bottles.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for food recalls:

  1. Return it to the store where you bought it, or throw it away.
  2. Don't give it to anyone else, such as a food bank, or to a pet.

Is yours affected?

Match the UPC and lot code listed under your product.

A UPC is the number printed under a barcode.

  1. Mellish Island Super Skin Dietary Supplement

    UPC
    • 8 58792 00332 3
    Lot code
    • CA1G24
    • 08-2027

Recall details

Company began the recall
Sold in

Product is distributed through TikTok exclusively. Presumably nationwide.

Company
Mellish Island CorpSan Dimas, California
Risk

Moderate risk

Eating it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99419
Recall number
H-1190-2026
Quantity recalled
1,600 bottles

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)